Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, and ...
Nanopore sequencing offers comparable accuracy to short-read NGS for IGH clonotyping in CLL, with advantages in cost and laboratory footprint. The study confirms reliable somatic hypermutation status ...
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, today announced a new collaboration with UK ...
ViruSure, an Asahi Kasei company and global leader in pathogen safety testing for biopharmaceuticals, today announced the launch of the world’s first GMP-validated adventitious viral agent (AVA) ...
Metagenomics is a revolutionary approach that allows scientists to examine the microbial composition of environmental or clinical samples. While this method enables them to characterize previously ...
Whole genome sequencing (WGS) is not necessarily a solution for someone with a rare, monogenic disease. Indeed, more than half of families with suspected rare monogenic diseases do not have an answer ...
Protein sequencing presents different challenges than nucleic acid sequencing, meaning that proteomics has yet to benefit as much as genomics from the next-generation sequencing revolution. However, ...
Chief Financial Officer Nick Keher outlined the company’s progress in expanding beyond its historically research-led revenue base, highlighting rapid growth in clinical and applied industrial end ...
Tina de los Reyes is the strategic biopharma development specialist for the Western US. With over 10 years of commercial experience in NGS and a Masters in Biomedical diagnostics, she specializes in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results